您当前所在的位置:首页 > 产品中心 > 产品信息
Atenolol_分子结构_CAS_29122-68-7)
点击图片或这里关闭

Atenolol

产品号 Bio-0737 公司名称 InterBioScreen
CAS号 29122-68-7 公司网站 http://www.ibscreen.com
分子式 C14H22N2O3 电 话 +7 49652 40091
分子量 266.33608 传 真 +7 49652 40092
纯 度 电子邮件 screen@ibscreen.chg.ru
保 存 Chembase数据库ID: 179869

产品价格信息

请登录

产品别名

标题
Atenolol
IUPAC标准名
2-{4-[(2S)-2-hydroxy-3-[(propan-2-yl)amino]propoxy]phenyl}acetamide
IUPAC传统名
2-{4-[(2S)-2-hydroxy-3-[(propan-2-yl)amino]propoxy]phenyl}acetamide
别名
Tenoblock
Atenol
Prenormin
Tenoretic
Atenix
Cuxanorm
Myocord
Selobloc
Tenormin
Totamol
Vasaten

产品登记号

CAS号 29122-68-7

产品性质

应用领域 Antihypertensive agent
应用领域 Can be used to treat cardiovascular diseases and conditions such as hypertension, coronary heart disease, arrhythmias, angina (chest pain) and
应用领域 to treat and reduce the risk of heart complications following myocardial infarction (heart attack)
生物活性机理 Beta-Adrenergic blocker
生物活性机理 Beta1-receptor specific antagonist

产品详细信息

参考文献

  • U.K. Pat., 1975, 1 391 444; CA, 83, 96783v, (synth)
  • Brown, H.C. et al., Clin. Pharmacol. Ther. (St. Louis), 1976, 20, 524, (pharmacol)
  • Heel, R.C. et al., Drugs, 1979, 17, 425, (rev)
  • Fitzgerald, J.D., Pharmacol. Biochem. Prop. Drug Subst., 1979, 2, 98, (rev, pharmacol)
  • Marmo, E., Drugs Exp. Clin. Res., 1980, 6, 639, (rev)
  • Caplar, V. et al., Acta Pharm. Jugosl., 1983, 33, 71; CA, 99, 187098, (rev, props)
  • Robertson, J.I.S. et al., Drugs, Vol. 25, Suppl. 2: -Blockade in the 1980s - Focus on Atenolol, ADIS Press, 1983, (book)
  • Caplar, V. et al., Anal. Profiles Drug Subst., 1984, 13, 1, (rev)
  • Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 3332, (synonyms)
  • Mehvar, R. et al., J. Pharm. Sci., 1990, 79, 881; 1991, 80, 207, (pharmacokinet, isomers)
  • Wadworth, A.N. et al., Drugs, 1991, 42, 468, (rev)
  • Bevinakatti, H.S. et al., J.O.C., 1992, 57, 6003, (bibl, synth, isomers, pmr, ir)
  • Carlsen, P.H.J. et al., Acta Chem. Scand., 1994, 48, 273, (synth, ms)
  • Cruickshank, J.M. et al., Beta-blockers in Clinical Practice, 2nd edn., Churchill Livingstone, Edinburgh, 1994, (book)
  • Kleidernigg, O.P. et al., Chirality, 1994, 6, 411, (synth, hplc, gc-ms)
  • McCoy, R.A. et al., J. Clin. Pharmacol., 1994, 34, 816, (pharmacol, isomers)
  • Reid, J.L. et al., Ann. N.Y. Acad. Sci., 1995, 763, 673, (rev)
  • Kitaori, K. et al., Chem. Pharm. Bull., 1997, 45, 412; 1998, 46, 505-507, (synth, pmr, cmr)
  • Martindale, The Extra Pharmacopoeia, 32nd edn., Pharmaceutical Press, 1999, 825
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, TAL475